HIGHLIGHTS
- who: Peter H. Gann and collaborators from the Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, United States of America, Department of Public Health Sciences, New Mexico State have published the paper: Development of a Nuclear Morphometric Signature for Prostate Cancer Risk in Negative Biopsies, in the Journal: PLOS ONE | www.plosone.org of July/26,/2013
- what: The authors focus on quantification of nuclear DNA patterns as a biomarker for the early stage of pre-neoplastic change in benign prostatic epithelium a stage associated with field effects or field cancerization . In the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.